Skip to search formSkip to main contentSkip to account menu

ML 3403

Known as: ML-3403, ML3403 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Molecular Cloning and Characterization of a P38-Like Mitogen-Activated Protein Kinase from Echinococcus granulosus
Cystic echinococcosis (CE) treatment urgently requires a novel drug. The p38 mitogen-activated protein kinases (MAPKs) are a… 
2012
2012
Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis.
2010
2010
Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle.
2010
2010
M1739 Ml3403, a New p38 MAPK Inhibitor, Corrects Immune Dysfunction in Rodent Models of Chronic Inflammatory Disorders
2010
2010
Digestive Disease Week 2010. Turning Science into Medicine--part 1.
  • L. Hodgkinson
  • IDrugs : the investigational drugs journal
  • 2010
  • Corpus ID: 44822576
The Digestive Disease Week 2010 conference, held in New Orleans, included topics covering new therapeutic developments in the… 
2008
2008
Role of recombinant mitogen-activated protein kinases JNK and p38 in the regulation of apoptosis in blood mononuclear cells under conditions of oxidative stress in vitro
Programmed death of peripheral blood mononuclear cells from healthy donors was studied during culturing with various… 
2007
2007
In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MS
Prediction of the metabolic profile of a potential new drug is recommended at an early stage in industrial drug discovery process… 
2007
2007
Pharmacokinetics of ML3403 ({4-[5-(4-Fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-Type p38 Mitogen-Activated Protein Kinase Inhibitor
The p38 mitogen-activated protein kinase (MAPK) is a key mediator in cytokine-induced signaling events that are activated in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)